[Clinical and bacteriological evaluation of the efficacy of rondomycin following a 3-year interruption in its administration].
D000293:Adolescent; D000328:Adult; D000368:Aged; D004352:Drug Resistance, Microbial; D004926:Escherichia coli / Q000187:drug effects; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008690:Methacycline / Q000494:pharmacology / Q000627:therapeutic use*; D008875:Middle Aged; D013210:Staphylococcus / Q000187:drug effects; D013997:Time Factors
D008690:Methacycline
Kliniczna i bakteriologiczna ocena skuteczności działania rondomycyny po 3-letniej przerwie w jej stosowaniu.